About this item:

60 Views | 22 Downloads

Author Notes:

Stamatina Iliodromiti, Email: s.iliodromiti@qmul.ac.uk

SI, JMcL, JMRG, NS and MAL conceived the idea, SI and JMcL conducted the systematic search, and SI performed the statistical analysis and wrote the first draft. NG and SI conducted the primary studies that provided the unpublished MRI and liver spectroscopy data. SB, JP, JF and SH performed the fat measurements using the primary magnetic resonance images and liver spectroscopy data from the unpublished studies. MRM, ODL and JL measured the fat in MRI images from the UK Biobank data. UPG and AK collected data for the largest primary study included in the meta-analysis. All authors edited and critically assessed the final version of the paper, and gave final approval of the version to be published. JMRG is responsible for the integrity of this work as a whole.

The imaging data from the UK Biobank Resource were provided under application 6569. We thank the UK Biobank participants and coordinators for this unique dataset. The authors thank L. Coyle, University of Glasgow, for her assistance with manuscript preparation.

MRM is employed by and has shareholdings in Pfizer Inc. ODL is employed by and has shareholdings in AMRA Medical AB. JL is employed by AMRA Medical AB. NS reports personal fees from Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer and Sanofi; and grant funding paid to his university from AstraZeneca, Boehringer Ingelheim, Novartis and Roche Diagnostics outside the submitted work. The remaining authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.

Subjects:

Research Funding:

There was no primary direct funding for undertaking the systematic review and meta-analysis and authors of the study were supported by their affiliated organisations/institutions during the conduct of the research

The study was partially supported by funding from the European Federation of Pharmaceutical Industries Associations (EFPIA)-Innovative Medicines Initiative (IMI) Joint Undertaking-European Medical Information Framework (EMIF) (grant no. 115372).

SI is funded by a Medical Research Council postdoctoral fellowship (MR/N015177/1). The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Endocrinology & Metabolism
  • Abdominal
  • Computed tomography
  • Fat
  • Liver
  • Magnetic Resonance Imaging
  • Meta-analysis
  • South Asian
  • Systematic review
  • Visceral
  • CORONARY-HEART-DISEASE
  • INSULIN-RESISTANCE
  • CENTRAL OBESITY
  • RISK
  • PREVALENCE
  • MORTALITY
  • ENGLAND
  • COUNTRY
  • WALES
  • BIRTH

Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data

Show all authors Show less authors

Tools:

Journal Title:

DIABETOLOGIA

Volume:

Volume 66, Number 1

Publisher:

, Pages 44-56

Type of Work:

Article | Final Publisher PDF

Abstract:

Aims/hypothesis: South Asians have a two- to fivefold higher risk of developing type 2 diabetes than those of white European descent. Greater central adiposity and storage of fat in deeper or ectopic depots are potential contributing mechanisms. We collated existing and new data on the amount of subcutaneous (SAT), visceral (VAT) and liver fat in adults of South Asian and white European descent to provide a robust assessment of potential ethnic differences in these factors. Methods: We performed a systematic review of the Embase and PubMed databases from inception to August 2021. Unpublished imaging data were also included. The weighted standardised mean difference (SMD) for each adiposity measure was estimated using random-effects models. The quality of the studies was assessed using the ROBINS-E tool for risk of bias and overall certainty of the evidence was assessed using the GRADE approach. The study was pre-registered with the OSF Registries (https://osf.io/w5bf9). Results: We summarised imaging data on SAT, VAT and liver fat from eight published and three previously unpublished datasets, including a total of 1156 South Asian and 2891 white European men, and 697 South Asian and 2271 white European women. Despite South Asian men having a mean BMI approximately 0.5–0.7 kg/m2 lower than white European men (depending on the comparison), nine studies showed 0.34 SMD (95% CI 0.12, 0.55; I2=83%) more SAT and seven studies showed 0.56 SMD (95% CI 0.14, 0.98; I2=93%) more liver fat, but nine studies had similar VAT (−0.03 SMD; 95% CI −0.24, 0.19; I2=85%) compared with their white European counterparts. South Asian women had an approximately 0.9 kg/m2 lower BMI but 0.31 SMD (95% CI 0.14, 0.48; I2=53%) more liver fat than their white European counterparts in five studies. Subcutaneous fat levels (0.03 SMD; 95% CI −0.17, 0.23; I2=72%) and VAT levels (0.04 SMD; 95% CI −0.16, 0.24; I2=71%) did not differ significantly between ethnic groups in eight studies of women. Conclusions/interpretation: South Asian men and women appear to store more ectopic fat in the liver compared with their white European counterparts with similar BMI levels. Given the emerging understanding of the importance of liver fat in diabetes pathogenesis, these findings help explain the greater diabetes risks in South Asians. Funding: There was no primary direct funding for undertaking the systematic review and meta-analysis. Graphical abstract: [Figure not available: see fulltext.]

Copyright information:

© The Author(s) 2022

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote